Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 2, 1999, Pages 165-172

  Tassani, P ^a   Richter, Josef A ^a   Barankay, Andreas ^a   Braun, Sigmund L ^a   Haehnel, Christoph ^a   Spaeth, Paul ^a   Schad, Hubert ^a   Meisner, Hans ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aprotinin; Methylprednisolone; Oxygenation; Pulmonary function; SIRS; Systemic inflammatory response syndrome

Indexed keywords

APROTININ; METHYLPREDNISOLONE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATION; LUNG ALVEOLUS OXYGEN TENSION; LUNG COMPLIANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; OXYGENATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032911443     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90081-2     Document Type: Article

References (52)

1. Replogle RL, Gazzaniga AB, Gross RE: Use of corticosteroids during cardiopulmonary bypass: Possible lysosome stabilization. Circulation 33:186-191, 1966 (suppl I)
2. Dietzman RH, Lunseth JB, Goott B, Berger E: The use of methylprednisolone during cardiopulmonary bypass. J Thorac Cardiovasc Surg 69:870-873, 1975
3. Engelman RM, Rousou JA, Flack JE, et al: Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 60:801-804, 1995
4. Hill GE, Alonso A, Spurzem JR, et al: Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 110:1658-1662, 1995
5. Teoh KHT, Bradley CA, Gauldie J, Burrows H: Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 92:347-353, 1995
6. Kawamura T, Inada K, Okada H, et al: Methylprednisolone inhibits increase of interleukin-8 and -6 during open heart surgery. Can J Anaesth 42:399-403, 1995
7. Tabardel Y, Duchateau J, Schmartz D, et al: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 119:76-80, 1996
8. Seghaye M, Duchateau J, Bruniaux J, et al: Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 111:545-553, 1996
9. Deng MC, Dash B, Erren M, et al: Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 62:184-190, 1996
10. Hennein HA, Ebba H, Rodriguez JL, et al: Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108:626-635, 1994
11. Dietrich W, Spannagl M, Jochum M, et al: Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73:1119-1126, 1990
12. Soeparwata R, Hartman AR, Frerichmann U, et al: Aprotinin diminishes inflammatory processes. Int J Cardiol 53:S55-S63, 1996 (suppl)
13. Ashraf S, Tian Y, Cowan D, et al: "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg 63:68-73, 1997
14. Seghaye MC, Duchateau J, Grabitz RG, et al: Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 61:1205-1211, 1996
15. Chaney MA, Nikolov MP, Blakeman B, et al: Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 87:27-33, 1998
16. Pölönen P, Hippeläinen M, Takala R, et al: Relationship between intra- and postoperative oxygen transport and prolonged intensive care after cardiac surgery: A prospective study. Acta Anaesthesiol Scand 41:810-817, 1997
17. Ranucci M, Cirri S, Conti D, et al: Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction. Ann Thorac Surg 61:76-81, 1996
18. Hattler BG, Zeevi A, Oddis CV, Finkel MS: Cytokine induction during cardiac surgery: Analysis of TNF-alpha expression pre- and post-cardiopulmonary bypass. J Cardiac Surg 10:418-422, 1995
19. Jansen NJG, van Oeveren W, Gu YJ, et al: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744-748, 1992
20. Butler J, Chong GL, Baigrie RJ, et al: Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 53:833-838, 1992
21. Haeffner-Cavaillon N, Roussellier N, Ponzio O, et al: Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 98:1100-1106, 1989
22. Kawamura T, Wakusawa R, Okada K, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin-8 and -6 in reperfusion injury. Can J Anaesth 40:1016-1021, 1993
23. Jorens PG, De Jongh R, De Backer W, et al: Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis 148:890-895, 1993
24. Kalfin RE, Engelman RM, Rousou JA, et al: Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 88:401-406, 1993
25. McBride WT, Armstrong MA, Crockard AD, et al: Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth 75:724-733, 1995
26. Tárnok A, Hambusch J, Schneider P: Cardiopulmonary bypass-induced increase of serum interleukin-10 levels in children. J Thorac Cardiovasc Surg 115:475-477, 1998
27. Jansen NJG, van Oeveren W, van den Broek L, et al: Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 102:515-525, 1991
28. Inaba H, Kochi A, Yorozu S: Suppression by methylprednisolone of augmented plasma endotoxin-like activity and interleukin-6 during cardiopulmonary bypass. Br J Anaesth 72:348-350, 1994
29. Andersen LW, Baek L, Thomson BS, Rasmussen JP: Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Vasc Anesth 3:544-549, 1989
30. Engelman RM, Rousou JA, Flack JE, et al: Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 60:801-804, 1995
31. Tabardel Y, Duchateau J, Schmartz D, et al: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 119:76-80, 1996
32. Cronstein BN, Kimmel SC, Levin RI, et al: A mechanism for the anti-inflammatory effects of corticosteroids: The glucocorticoids receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 89:9991-9995, 1992
33. Derendorf H, Hochhaus G, Mollmann H, et al: Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol 33:115-123, 1993
34. Derendorf H, Mollmann H, Krieg M, et al: Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers. Pharm Res 8:263-268, 1991
35. Kong AN, Jungbluth GL, Pasko MT, et al: Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass. Pharmacotherapy 10:29-34, 1990
36. Diego RP, Mihalakakos PJ, Hexum TD, Hill GE: Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11:29-31, 1997
37. Karlstad MD, Patteson SK, Guszcza JA, et al: Methylprednisolone does not influence endotoxin translocation during cardiopulmonary bypass. J Cardiothorac Vase Anesth 7:23-27, 1993
38. Hill GE, Alonso A, Thiele GM, Robbins RA: Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg 79:23-27, 1994
39. Gurevitch J, Barak J, Hochhauser E, et al: Aprotinin improves myocardial recovery after ischemia and reperfusion: Effects of the drug on isolated rat hearts. J Thorac Cardiovasc Surg 108:109-118, 1994
40. Bukhari EA, Krukenkamp IB, Burns PG, et al: Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning? Ann Thorac Surg 60:307-310, 1995
41. Wachtfogel YT, Kucich U, Hack CE, et al: Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 106:1-9, 1993
42. Jansen PGM, Baufreton C, Le Besnerais P, et al: Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting. Ann Thorac Surg 61:1363-1366, 1996
43. Hill GE, Whitten CW, Landers DF: The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J Cardiothorac Vasc Anesth 11:367-375, 1997
44. Wachtfogel YT, Hack CE, Nuijens JH, et al: Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation. Am J Physiol 268:H1352-H1357, 1995
45. Boldt J, Osmer C, Schindler E, et al: Circulating adhesion molecules in cardiac operations: Influence of high-dose aprotinin. Ann Thorac Surg 59:100-105, 1995
46. Ungureanu-Longrois D, Balligand JL, Simmons WW, et al: Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res 77:494-502, 1995
47. Shindo T, Ikeda U, Ohkawa F, et al: Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 29:813-819, 1995
48. Hill GE, Springall DR, Robbins RA: Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery 121:449-455, 1997
49. Hill GE, Robbins RA: Aprotinin but not tranexamic acid inhibits cytokine-induced inducible nitric oxide synthase expression. Anesth Analg 84:1198-1202, 1997
50. Hill G, Taylor J, Robbins RA: Differing effects of aprotinin and e-aminocaproic acid on cytokine-induced inducible nitric oxide synthase expression. Ann Thorac Surg 63:74-77, 1997
51. Hill GE, Whitten CW: The role of the vascular endothelium in inflammatory syndromes, atherogenesis, and the propagation of disease. J Cardiothorac Vasc Anesth 11:316-321, 1997
52. Mayumi H, Zhang QW, Nakashima A, et al: Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg 63:129-137, 1997